6Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
7Weng HL,Wang BE,Jia JD,et al.Effect of interferon 2gamma On hepatic fibrosis in chronic hepatitis B virus infection:a randomized controlled study[J].Clin Gastroenterol Hepatol,2005,3:818-828.
8Li D.Friedman SL.Liver fibrogenesis and the role of hepatic stellate cells:new insights and prospects for therapy[J].J Gastroenterol Hepatol,1999,14:618-633.
9Hadziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Long-term therapy with adefovir dip ivoxil for HBeAg-negative chronic hepatitis B[J].N Engi J Med,2005,352:2673-2681.
10Delaney W,Yang H,Qix,et al.In vitro cross-resistence testing of adefovir,lamivudine,telbivudine(L-DT),entecavir and other anti-HBV compounds against four major mutational patterns of lamivudine-resistant HBV[J].Hepatology,2004,40 (4):244A-181.
